PERRY CHRISTOPHER JOHN 4

4 · BROADRIDGE FINANCIAL SOLUTIONS, INC. · Filed Mar 10, 2025

Form 4

Period: 2025-03-07

DirectorPresident

Transactions

Sale
Common Stock
2025-03-07$235.23/sh−7,021$1,651,549→ 61,018.521 total
Exercise/Conversion
Common Stock
2025-03-07$144.84/sh+7,549$1,093,397→ 74,880.521 total
Exercise/Conversion
Common Stock
2025-03-07$144.67/sh+9,376$1,356,426→ 59,612.521 total
Sale
Common Stock
2025-03-07$235.23/sh−6,841$1,609,208→ 68,039.521 total
Exercise/Conversion
Common Stock
2025-03-07$148.07/sh+7,719$1,142,952→ 67,331.521 total
Sale
Common Stock
2025-03-07$235.23/sh−8,495$1,998,278→ 52,523.521 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-03-07−7,549→ 7,549 total
Exercise: $144.84From: 2023-02-14Exp: 2032-02-14→ Common Stock (7,549 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-03-07−9,376→ 18,751 total
Exercise: $144.67From: 2024-02-15Exp: 2033-02-15→ Common Stock (9,376 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-03-07−7,719→ 0 total
Exercise: $148.07From: 2022-02-12Exp: 2031-02-12→ Common Stock (7,719 underlying)

Footnotes (1)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.00 - $236.43, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Documents

1 file